We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Passes Bills on Continuous Manufacturing, the National Stockpile and Counterfeit Products
House Passes Bills on Continuous Manufacturing, the National Stockpile and Counterfeit Products
The House of Representatives on Monday passed three bipartisan pharma bills, all by voice votes, aimed at promoting continuous drug manufacturing, the release of drugs from the Strategic National Stockpile and extending the FDA’s authority for counterfeit products.